“LL-37”的搜索结果，显示 241-250 项，共有 6975 项

  1. 神经科- 临床试验- 妙佑医疗国际

    Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

  2. 神经科- 临床试验- 妙佑医疗国际

    ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme ...

  3. 精神病与心理科- 临床试验- 妙佑医疗国际

    Go to page 22 · Go to page 33 · Go to page 44 · NextNext Page · 申请预约 · 专业团队研究. May 10, 2025. Share on: FacebookTwitter WeChat. WeChat. Close. Weibo ...

  4. 耳鼻喉科 (ENT) /头颈外科 - 临床试验 - 妙佑医疗国际

    Go to page 22 · Go to page 33 · NextNext Page. 以下为当前的临床试验。 23 研究 耳鼻喉科 (ENT) /头颈外科 （仅限开放性研究）. 按位置、状态和其他条件筛选该研究列表 ...

  5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    [1, 2] The solid tumor stroma acts as an immunosuppressive cloud that ... 2-year progression free survival (PFS) rate as compared to ACNS0122. Also ...

  6. 神经科- 临床试验- 妙佑医疗国际

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

  7. 神经科- 临床试验- 妙佑医疗国际

    ... 2 participants will also undergo MRI scanning, comprehensive cognitive ... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying ...

  8. 心血管医学- 临床试验- 妙佑医疗国际

    Rochester, Minn. Spontaneous coronary artery dissection (SCAD) is uncommon but important cause of acute coronary syndrome and sudden cardiac death. There is ...

  9. 外科 - 临床试验- 妙佑医疗国际

    Go to page 22 · Go to page 33 · Go to page 44 · Go to page 55 · Go to page 66 · NextNext Page. 以下为当前的临床试验。 120 研究外科（仅限仍在招募的研究）. 按院区 ...

  10. 肌张力障碍- 医生与科室

    2 · 3. 研究. 在研究肌张力障碍和其他运动障碍方面，妙佑医疗国际的研究人员有着辉煌的历史。妙佑医疗国际的神经科医生们发现了导致肌张力障碍的基因，建立了以前被忽略 ...